Prognostic Factors of Melanoma Patients with Satellite or In-Transit Metastasis at the Time of Stage III Diagnosis
Open Access
- 29 April 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (4), e63137
- https://doi.org/10.1371/journal.pone.0063137
Abstract
Prognosis of patients with loco-regional skin metastases has not been analyzed in detail and the presence or absence of concurrent lymph node metastasis represents the only established prognostic factor thus far. Most studies were limited to patients already presenting with skin lesions at the time of initial diagnosis. We aimed to analyze the impact of a broad penal of prognostic factors in patients with skin metastases at the time of first metastatic spread, including patients with synchronous lesions already present at the time of initial diagnosis, stage I/II patients with loco-regional recurrence and patients initially presenting with skin metastasis but unknown primary melanoma. We investigated disease-specific survival of 380 patients treated at our department between 1996 and 2010 using Kaplan Meier survival probabilities and Cox-proportional hazard analysis. Five-year survival probability was 60.1% for patients with skin metastases only and 36.3% for those with synchronous nodal metastases. The number of involved nodes and a tumor thickness of at least 3 mm had independent negative impact on prognosis. A strong relationship was identified between the risk of death and the number of involved nodes. Neither ulceration nor the timing of the first occurrence of metastases as either in stage I/II patients, at the time of excision of the primary melanoma or initially in patients with unknown primary tumor, had additional effects on survival. Lymph node involvement was confirmed as the most important prognostic factor for melanoma patients with loco-regional skin metastasis including those with unknown primary tumor and stage I/II patients with skin recurrence. Consideration of the tumor thickness and of the number of involved lymph nodes instead of the exclusive differentiation into presence vs. absence of nodal disease may allow a more accurate prediction of prognosis for patients with satellite or in-transit metastases.Keywords
This publication has 20 references indexed in Scilit:
- Mitotic rate and subcutaneous involvement are prognostic factors for survival after recurrence in patients with only locoregional skin metastasis as the first site of recurrence from cutaneous melanomaJournal of the European Academy of Dermatology and Venereology, 2012
- Contemporary Surgical Treatment of Advanced-Stage MelanomaArchives of Surgery, 2004
- Primary melanoma tumour regression associated with an immune response to the tumour‐associated antigen melan‐A/MART‐1International Journal of Cancer, 2001
- Final Version of the American Joint Committee on Cancer Staging System for Cutaneous MelanomaJournal of Clinical Oncology, 2001
- Prognostic factors of overall survival in patients with delayed lymph node dissection for cutaneous malignant melanomaMelanoma Research, 2000
- Factors affecting survival following local, regional, or distant recurrence from localized melanomaJournal of Surgical Oncology, 1998
- Survival with regional and distant metastases from cutaneous malignant melanoma.1991
- Multivariate analysis of prognostic factors in regional cutaneous metastases of extremity melanomaCancer, 1988
- Factors influencing the survival of patients with regional melanoma of the extremity treated by perfusion.1987
- Prognostic parameters in recurrent malignant melanomaCancer, 1983